Skip to content
bioinnovationbeacon.com

bioinnovationbeacon.com

  • Home
  • AI
  • Biotech News
  • Research
  • Technology
  • Press Releases
  • Privacy Policy
  • Contact Us

Category: Regeneron

Regeneron’s POTS antibody curbs heart rate spikes, teeing up Phase 3 trial
RegeneronResearch and Discovery

Regeneron’s POTS antibody curbs heart rate spikes, teeing up Phase 3 trial

A single dose of Regeneron Pharmaceuticals’ investigational monoclonal antibody reduced orthostatic heart rate at eight days for patients with a…

byadminNovember 13, 2026

| Depth News by Ascendoor | Powered by WordPress.